HoldsUp

DavidPerlmutterMD · 2025-03-24 · David Perlmutter (host), Dale Bredesen

How to Make Your Brain Ageless: Prevent Cognitive Decline & Supercharge Your Mind | Dale Bredesen

43 research-tied claims examined: 1 contradicted 5 overstated 3 context 28 supported 6 unverified

5

Overstated

0:05:53Dale Bredesenoverstatedvery low

A published paper demonstrates over a decade of sustained cognitive and MRI improvement in patients treated with a precision medicine approach for cognitive decline.

"we just published a paper freely available online, over a decade of improvement in some of these people—then you can't really deny it." (said at 0:05:53)

A 2024 open-access case series reported sustained cognitive improvement spanning up to a decade in selected patients undergoing a personalized, multi-component precision medicine protocol (the ReCODE protocol). However, presenting an uncontrolled case series as undeniable proof of treatment efficacy overstates the scientific strength of the evidence. Uncontrolled case series cannot rule out selection bias, practice effects, natural fluctuation, or concurrent confounders, and the study authors themselves noted that controlled, long-term cohort studies are required to establish efficacy and frequency of response.

0:22:24Dale Bredesenoverstatedlow

Chronic, long-term stress alone causes the human brain to shrink.

"And as you know, just having long-term stress will shrink your brain, that alone." (said at 0:22:24)

The speaker's claim that long-term stress alone causes the human brain to shrink is overstated. Observational and neuroimaging studies show that chronic perceived stress and elevated circulating stress hormones (such as cortisol) are associated with reduced volume in specific brain regions (notably the hippocampus and prefrontal cortex) and lower total cerebral brain volume (an association observed particularly in women in large cohort studies such as the Framingham Heart Study). However, evidence in humans is primarily cross-sectional and observational rather than definitive proof of isolated causation ('that alone'), and volume reductions are regional, variable across sexes, and influenced by genetic and environmental modifiers.

0:12:17Dale Bredesenoverstatedmoderate

The human brain contains approximately 500 trillion synapses.

"You have this beautiful network of 500 trillion synapses, and you begin to lose that as you are switching from a connection mode to a protection mode." (said at 0:12:17)

Unbiased stereological studies estimating total synapse counts in the human neocortex report approximately 150 to 164 trillion synapses (0.15 x 10^15), significantly fewer than the claimed 500 trillion.

1:01:40David Perlmutter (host)overstatedlow

Starting estrogen and progesterone replacement therapy at midlife or perimenopause provides greater Alzheimer's risk reduction than initiating it postmenopausally.

"what Dr. Lisa Mosconi demonstrated was that there really at least with estrogen/progesterone replacement that the benefits of midlife, commencing therapy at midlife, perimenopausal as opposed to waiting until postmenopausal, seem to be much better in terms of Alzheimer's risk reduction." (said at 1:01:40)

Research by Dr. Lisa Mosconi and other neuroscientists explores the 'critical window' or 'timing hypothesis' of menopausal hormone therapy (MHT), showing that estrogen exposure and early initiation during the menopausal transition are linked to preserved brain gray matter volume, metabolism, and biomarker profiles in Alzheimer's-vulnerable regions. However, claiming that starting therapy during perimenopause has been 'demonstrated' to provide clinical Alzheimer's risk reduction overstates the evidence: randomized trial data in midlife are lacking, observational data for combined estrogen-progestogen therapy show variable outcomes, and hormone therapy is not clinically approved or proven for dementia prevention.

1:01:07Dale Bredesenoverstatedlow

Progesterone plays an important functional role in physiological detoxification pathways.

"And then, of course, progesterone turns out to be very important as part of your detox mechanism." (said at 1:01:07)

While progesterone and its associated receptors (such as progesterone receptor membrane component 1, or PGRMC1) interact with hepatic cytochrome P450 (CYP) monooxygenase systems, progesterone is primarily a substrate that undergoes physiological detoxification and clearance by the liver, rather than serving as an essential driver of the body's detoxification pathways. In vitro and mechanistic reviews indicate that PGRMC1 interacts with and can modulate or even inhibit certain drug-metabolizing CYP enzymes (such as CYP2C8, CYP2C9, and CYP3A4) while activating sterol-synthesizing enzymes, rather than functioning as a general detoxification mechanism.

Unverified means no publication matching the claim was located; it does not prove the claim false. Spotted an error? See the corrections policy - disputes from the people quoted are prioritized.